---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285555751.md"
description: "Entrada Therapeutics shares are trading lower after the company reported mixed Q1 financial results."
datetime: "2026-05-07T12:46:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285555751.md)
  - [en](https://longbridge.com/en/news/285555751.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285555751.md)
---

# 

Entrada Therapeutics shares are trading lower after the company reported mixed Q1 financial results.

### Related Stocks

- [TRDA.US](https://longbridge.com/en/quote/TRDA.US.md)

## Related News & Research

- [Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Consensus Recommendation of "Hold" by Brokerages](https://longbridge.com/en/news/275529593.md)
- [Entrada Therapeutics Highlights Transformational Year and Pipeline Progress](https://longbridge.com/en/news/286898145.md)
- [Entrada Therapeutics updates corporate presentation, cites DMD Cohort 1 safety and functional gains; Cohort 2/45 data due 2026](https://longbridge.com/en/news/286891476.md)
- [Entrada's Duchenne drug shown to improve muscle function in early trial](https://longbridge.com/en/news/285535415.md)
- [Entrada Therapeutics DMD Trial Shows Early Functional Gains, Clean Safety Profile](https://longbridge.com/en/news/285798686.md)